DPP-4 inhibitors (weekly vs daily)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DPP-4 inhibitors (weekly vs daily), covering 2019-05-10 to 2019-05-10. Get the full timeline:
Most recent: Clinical Trial Update: Treatment Preference for Weekly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Versus Daily DPP-4 Inhibitors in Participants With Type 2 Diabetes Mellitus [Phase 4]